Clinical trial
The Effect of Riboflavin Supplementation on Faecalibacterium Prausnitzii in Crohn's Disease
NCT02538354 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Riboflavin Supplementation on Faecalibacterium Prausnitzii in Crohn's Disease
- Lead sponsor
- University Medical Center Groningen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- April 30, 2017
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.